Autopsy report · NCT02524275
Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cause of deathSlow enrollment
“low enrollment”
Life of this trial
- Registered 4 months after it had already started.
- Ran for about 6 years 7 months before it stopped.
- 14 participants enrolled.
- Results were posted on the registry 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Nebraska
- Sponsor type
- University, hospital or other
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Capecitabine; Docetaxel; Quality-of-Life Assessment; Questionnaire Administration
- Participants
- 14
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.